 |
 |
 |
|
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 24 Subgroup Analysis
|
|
|
Reported by Jules Levin
Infectious Disease Week
October 8-12, 2014
Philadelphia, PA
C Brinson,1 J Lalezari,2 GH Latiff,3 M Thompson,4 J Echevarrķa,5
S Trevino-Perez,6 D Stock,7 SR Joshi,7 GJ Hanna,8 M Lataillade7
for the AI438011 study team
1Central Texas Clinical Research, Austin, TX, USA; 2. Quest Clinical Research, San Francisco, CA, US; 3. Maxwell Clinic, Durban, South Africa; 4. AIDS Research Consortium of Atlanta, Atlanta, USA; 5. Hospital Nacional Cayetano Heredia, Lima, Peru; 6. Mexico Centre for Clinical Research, Mexico City, Mexico; 7. Bristol-Myers Squibb, Wallingford, CT, USA; 8. Bristol-Myers Squibb, Princeton, NJ, USA.

















|
|
|
 |
 |
|
|